MedPath

7-DAY VERSUS 10-DAY INTRAVENOUS ANTIBIOTICSFORNEONATAL SEPSIS:A RANDOMIZED CONTROLLED TRIA

Phase 4
Completed
Conditions
Health Condition 1: A499- Bacterial infection, unspecifiedHealth Condition 2: null- Neonatal septicemia
Registration Number
CTRI/2013/01/003302
Lead Sponsor
niversity College of Medical Sciences and Guru Teg Bahadur Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
132
Inclusion Criteria

Neonates delivered at �32 weeks gestation (according to modified Ballard scoring and a birth weight �1.5kg,with symptomatic culture positive sepsis.Both early and late onset neonatal sepsis will be included in the study.

Exclusion Criteria

Deep seated infections-meningitis, osteomyelitis,septic arthritis

Severe birth asphyxia (1 minute Apgar score � 3)

Gross congenital anomalies

Symptoms persisting (non-remittance) after 5 days of antibiotic therapy

Fungal sepsis

Neonates residing outside 15 kms radius of GTB Hospital,Delhi.

Neonates requiring central line

Neonates requiring exchange transfusion

Neonates on mechanical ventilation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment failure: Defined by the reappearance of signs and symptoms of sepsis within 28 days of stopping antibiotics, supported by the presence of a positive blood culture growing the same organism as cultured earlier (according to the similar antibiogram as obtained previously or strain typing by pulse field gel electrophoresis where possible), OR in the absence of a positive culture, the presence of reactive CRP and as adjudicated by an expert committee.Timepoint: Within first 28 days of stopping antibiotics
Secondary Outcome Measures
NameTimeMethod
To correlate treatment failure in both groups with: <br/ ><br>ïâ??§Positive C-reactive protein on day 7 of antibiotic therapy <br/ ><br>ïâ??§The type of pathogen isolated <br/ ><br>ïâ??§Duration of hospital stay <br/ ><br>2.To see if the pathogen implicated in relapse correlates with the pathogen isolated in the stool culture/rectal swab on the day of discharge. <br/ ><br>Timepoint: 7 days; within 28 days of discharge
© Copyright 2025. All Rights Reserved by MedPath